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Abstract 
 
Surfactants are used as additives in topical pharmaceuticals and drug delivery systems. 
The biocompatibility of amino acid-based surfactants makes them highly suitable for use 
in these fields, but tests are needed to evaluate their potential toxicity. Here we addressed 
the sensitivity of tumor (HeLa, MCF-7) and non-tumor (3T3, 3T6, HaCaT, NCTC 2544) 
cell lines to the toxic effects of lysine-based surfactants by means of two in vitro 
endpoints (MTT and NRU). This comparative assay may serve as a new approach for 
predictive toxicity screening of chemicals prior to pharmaceutical applications. After 24-h 
of cell exposure to surfactants, differing toxic responses were observed. NCTC 2544 and 
3T6 cell lines were the most sensitive, while both tumor cells and 3T3 fibroblasts were 
more resistant to the cytotoxic effects of surfactants. IC50 -values revealed that 
cytotoxicity was detected earlier by MTT assay than by NRU assay, regardless of the 
compound or cell line. The overall results showed that surfactants with organic 
counterions were less cytotoxic than those with inorganic counterions. Our findings 
highlight the relevance of the correct choice and combination of cell lines and bioassays in 
toxicity studies for a safe and reliable screen of chemicals with potential interest in 
pharmaceutical industry. 
 
 
 
Keywords: lysine-based surfactants; cytotoxicity; cell sensitivity; MTT; NRU; 
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1. Introduction 
 
Surfactants represent one of the most widely applied excipients in the 
pharmaceutical and cosmetic industry due to their surface and interface activities. In order 
to minimize adverse reactions derived from the toxic potential of surfactants, the type of 
surfactant and concentration used should be considered when designing products for 
preformulation trials (Benassi et al., 2003; Paulsson and Edsman, 2001). Our previous 
research into new surfactants with low toxicity and a wide range of applications led to the 
development of a range of biocompatible surfactants derived from amino acids 
(Benavides et al., 2004a,b; Martinez et al., 2006; Mitjans et al., 2003). In this context, 
amino acid-based surfactants constitute a promising choice for applications in topical 
pharmaceutical products, as well as in novel biocompatible drug delivery devices (Morán 
et al., 2010; Nogueira et al., 2011). As the surface properties (hydrophobicity and surface 
charge) have a major impact on cellular uptake of particulate drug delivery systems, the 
incorporation of charged surfactants in these carriers may improve the targeting to specific 
cells and tissues, e.g. in cancer therapy (Schöler et al., 2001).  Before this class of 
compounds can be approved for these purposes, however, accurate information about their 
toxicity is required. Thus, a complete toxicological evaluation of their effects should be 
performed by comparing a battery of complementary in vitro bioassays (Fisher et al., 
2003).  
Safety evaluation of new products or ingredients destined for human use is crucial 
prior to exposure. Therefore, rapid, sensitive and reliable bioassays are required in order 
to examine the toxicity of these substances. Established cell lines are useful alternative 
test systems for toxicological studies of this kind (Crespi, 1995); however, they must be 
chosen with care with regards their origin (Jondeau et al., 2006). Moreover, cytotoxicity 
assays are among the most common in vitro endpoints used to predict the potential 
toxicity of a substance in a cell culture (Martinez et al., 2006). Cell damage is manifested 
in several ways, including mitochondrion and plasma membrane dysfunction and, 
fluctuating intracellular reduction capacity (Kim et al., 2009). Current standard 
approaches to gauge the degree of cell damage include assays that measure various 
aspects of cell viability, such as metabolic activity and plasma membrane integrity. The 
MTT reduction assay, which determines cell metabolic activity, is among the most 
commonly used endpoints. This method measures the reduction of MTT salt to a colored 
insoluble formazan in active mitochondria in viable cells and also, in certain cases, 
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outside the mitochondria (Berridge et al., 2005; Liu et al., 1997). The neutral red uptake 
(NRU) assay, which is also widely used in biomedical applications, measures the uptake 
of neutral red dye by viable cells with intact plasma membrane, and its concentration in 
lysosomes (Repetto et al., 2008). Differences in the sensitivity of endpoints, together with 
the type of cell model and the nature of the chemicals being tested, may explain 
inconsistencies in the results reported (Schröterová et al., 2009). Therefore, 
complementary endpoint assays based on various mechanisms, as well as comparative 
analysis of the sensitivity of several cell types, are strongly recommended to increase the 
reliability of results (Fischer et al., 2003; Schröterová et al., 2009).   
 Here we studied the sensitivity of two tumor and four non-tumor cell lines of 
different origins to the toxic effects of five anionic lysine-based surfactants that differ in 
the nature of their counterions. The choice of dermal and tumor cells as model systems is 
based on the widely use of surfactants in topical pharmaceuticals and more recently in 
drug delivery devices (e.g. in cancer therapy), respectively. The knowledge about the 
cytotoxicity and potential mechanisms of surfactant interaction with healthy and tumor 
cells may help on the development of specific and effective devices for cancer therapy. In 
previous studies, we identified a number of toxic effects of this class of surfactants 
(Sanchez et al., 2004, 2006a, 2006b). Nevertheless, given that no single in vitro assay has 
the capacity to mimic all events that occur in vivo, and in order to complete these 
toxicological studies, here we performed a comparative evaluation using six cell types and 
two cytotoxicity assays, MTT and NRU. These two assays evaluate different cell 
physiological mechanisms and are considered to be the most common methods applied to 
study cell viability after exposure to toxic substances (Fotakis and Timbrell, 2006). To 
gain insight into structure-dependent toxicity, we also discuss the influence of the 
counterions on the cytotoxic effects of the surfactants. This comparative study performed 
using six cell lines and two in vitro endpoints can be considered a suitable approach for 
toxicological screening of chemical compounds prior to pharmaceutical applications. 
 
2. Materials and methods 
 
2.1. Chemicals and reagents 
L-lysine monohydrochloride, L-lysine, Tris, and the bases NaOH, LiOH and KOH 
were purchased from Merck (Darmstadt, Germany). 2,5-diphenyl-3,-(4,5-dimethyl-2-
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thiazolyl) tetrazolium bromide (MTT), neutral red (NR) dye and dimethylsulphoxide 
(DMSO) were from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco´s Modified Eagle´s 
Medium (DMEM), RPMI 1640 medium, fetal bovine serum (FBS), phosphate buffered 
saline (PBS), L-glutamine solution (200 mM), trypsin-EDTA solution (170,000 U/l
 
trypsin and 0.2 g/l EDTA) and penicillin-streptomycin solution (10,000 U/ml penicillin 
and 10 mg/ml streptomycin) were purchased from Lonza (Verviers, Belgium). The 75 cm
2
 
flasks and 96-well plates were obtained from TPP (Trasadingen, Switzerland). 
 
2.2. Surfactants tested 
 Five anionic amino acid-based surfactants derived from N
α
,N
ε –dioctanoyl lysine 
and with counterions of distinct chemical nature were studied: two salts with organic 
counterions - lysine salt (77KK) and tris(hydroxymethyl) aminomethane salt (77KT); and 
three salts with inorganic counterions - sodium salt (77KS), lithium salt (77KL) and 
potassium salt (77KP) (Fig. 1). These surfactants were synthesized in our laboratory as 
previously described (Sánchez et al., 2006a; Vives et al., 1999).  
 
2.3. Cell cultures 
 Two tumor cell lines (HeLa, human epithelial cervical cancer and MCF-7, human 
breast cancer) and four non-tumor cell lines (3T3, murine Swiss albino fibroblasts; 3T6, 
spontaneously transformed 3T3 murine Swiss albino fibroblasts; HaCaT, spontaneously 
immortalized human keratinocytes and NCTC 2544, normal human undifferentiated 
keratinocytes) were used. The 3T3, HeLa and MCF-7 cell lines were grown in DMEM 
medium (4.5 g/l glucose) supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 
U/ml penicillin and 100 µg/ml streptomycin. The HaCaT cell line was cultured under the 
same conditions as described above, except for supplementation with 10 mM Hepes 
buffer. The NCTC 2544 and 3T6 cell lines were cultured in RPMI 1640 medium 
supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 
µg/ml streptomycin. Cells were routinely grown in 75 cm
2
 culture flasks and maintained 
at 37 ºC in a humidified 5% CO2 atmosphere. Cells were trypsinized using trypsin-EDTA 
when they reached approximately 80% confluence.  
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2.4. Experimental design 
 Cells were seeded into the central 60 wells of 96-well cell culture plates in 100 µl 
of complete culture medium at the following initial densities (cells/ml): 1 x 10
5
 for MCF-
7, 8.5 x 10
4
 for 3T3 and HeLa, 5 x 10
4
 for 3T6, HaCaT and NCTC 2544. Cells were 
incubated for 24 h under 5% CO2 at 37 ºC and the medium was then replaced with 100 µl 
of fresh medium supplemented with 5% FBS containing 0.22-µm filter-sterilized 
surfactant solution at the required concentration (serial dilutions between 7.8-500 μg/ml). 
Each concentration was tested in triplicate and control cells were exposed to medium with 
5% FBS only. 
 
2.5. Cytotoxicity assays 
 
2.5.1. MTT assay 
 The MTT assay is based on the protocol first described by Mossmann (1983). In 
this assay, living cells reduce the yellow tetrazolium salt MTT to insoluble purple 
formazan crystals. After cell incubation for 24 h, the surfactant-containing medium was 
removed, and 100 µl of MTT in PBS (5 mg/ml) diluted 1:10 in FBS-free medium without 
phenol red was then added. Plates were further incubated for 3 h, after which time the 
medium was removed, and cells were washed in PBS. The purple formazan product was 
then dissolved by adding 100 µl of DMSO to each well. Plates were then placed in a 
microtitre-plate shaker for 10 min at room temperature and the absorbance of the resulting 
solutions was measured at 550 nm using a Bio-Rad 550 microplate reader. The effect of 
each treatment was calculated as the percentage of tetrazolium salt reduction by viable 
cells against the untreated cell control (cells with medium only). 
 
2.5.2. NRU assay 
 Based on the protocol described by Borenfreund and Puerner (1985), the NRU 
assay determines the accumulation of the NR dye in the lysosomes of viable, undamaged 
cells. Following exposure to the surfactants solutions, cells were incubated for 3 h with 
NR dye solution (50 µg/ml) dissolved in medium without FBS and phenol red. Cells were 
then washed with PBS, followed by the addition of 100 µl of a solution containing 50% 
ethanol absolute and 1% acetic acid in distilled water to extract the dye. Plates were gently 
shaken for 10 min to ensure complete dissolution. We then measured the absorbance of 
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the extracted solution at 550 nm using a Bio-Rad 550 microplate reader. The effect of 
each treatment was calculated as the percentage of uptake of NR dye by lysosomes against 
the untreated cell control (cells with medium only). 
 
2.6. Statistical analyses 
The cytotoxicity of each surfactant was expressed as percentage of viability with 
regard to untreated control wells (the mean optical density of untreated cells was set at 
100% viability) in terms of its IC50 (concentration causing 50% death of the cell 
population), calculated from concentration-response curves. Results are expressed as 
mean ± standard error of the mean (S.E.M.) of at least three independent experiments. 
Statistical analyses of the individual IC50 -values were performed using Student’s 
t-test or one-way analysis of variance (ANOVA) to determine the differences between the 
sets of data. Tukey’s posthoc multiple comparison test was also used to further identify 
significant differences between cell lines, as indicated, using the SPSS
® 
software (SPSS 
Inc., Chicago, IL, USA). p < 0.05, p < 0.01, p < 0.005 or p < 0.001 were considered to 
denote significance. Pearson’s correlation coefficients between the IC50 -values obtained 
from the cytotoxic assays and cell lines were also calculated by linear regression analysis. 
 
3. Results 
 
3.1. In vitro cytotoxicity of the compounds 
 Dose-response curves for each surfactant obtained from NRU and MTT assays in 
all six cell lines are given in Fig. 2 and 3, for the surfactants with organic and inorganic 
counterions, respectively. These cytotoxicity assays revealed that a 24 h-exposure of the 
tumor and non-tumor cell lines to different concentrations (ranging from 7.8 to 500 
µg/ml) of the five anionic lysine-based surfactants produced a dose-dependent reduction 
in the number of viable cells. Differences between cell lines as well as various sensitivity 
to the surfactants were demonstrated by calculating the half maximal inhibitory 
concentrations (IC50) (Fig. 4). IC50 -values ranged from 103.67 µg/ml (77KL with 3T6 
cells) to 468.53 µg/ml (77KL with MCF-7 cells), highlighting the wide cell sensitivity to 
these compounds. 
 Observation of IC50 -values shows that some cells lines were markedly less 
sensitive to the cytotoxic effects of the surfactants. In general, the tumor cell lines HeLa 
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and MCF-7 (Fig. 4e and f, respectively) and 3T3 fibroblasts (Fig. 4a) were more resistant 
to the deleterious effects of the surfactants, while 3T6 and NCTC 2544 cell lines (Fig. 4b 
and d, respectively) showed greater sensitivity, with IC50 -values lower than 200 µg/ml. 
By scoring the sensitivity of the cells to the five surfactants, we can ranked the cell lines 
from the most resistant to the most sensitive as follows: MCF-7 > 3T3 > HeLa > HaCaT > 
NCTC 2544 > 3T6 by the NRU assay, and 3T3 > MCF-7 >  HeLa > HaCaT > NCTC 
2544 > 3T6 by the MTT assay. 
 The levels of toxicity varied depending not only on cell line and substance tested, 
but also on the viability assay used. Regardeless of the compound or cell line, cytotoxicity 
was detected and observed earlier by the MTT assay. In contrast, the NRU assay was less 
sensitive and discriminative. The MTT assay (Fig. 2b and d, Fig. 3b, d and f) showed 
significant decrease in the metabolic activity of cells in a concentration-dependent manner 
and, in general, the lowest concentration of each surfactant that significantly reduced cell 
viability in all six cell lines ranged from 31.25 to 125 µg/ml. In contrast, no apparent 
cytotoxicity was detected when the same concentration range was assessed by the NRU 
assay (Fig. 2a and c, Fig. 3a, c and e). In this assay, significant loss of cell viability was 
detected for all the surfactants only at the highest concentrations tested (250 and 500 
µg/ml), except for 3T6 and NCTC 2544 cell lines, which showed greater sensitivity to the 
surfactants in both assays.  
 The surfactants differed only in the type of counterion, and the overall results 
showed that those with organic counterions (77KK and 77KT) were less cytotoxic than 
those with inorganic counterions (77KL, 77KP and 77KS). The IC50 -values for 77KK and 
77KT ranged from 129.07 to 404.37 µg/ml, thereby indicating that they were less 
cytotoxic than the surfactants with inorganic counterions. The relatively low IC50 -values 
for 77KS and 77KP, ranging from 113.97 µg/ml to 298.67 µg/ml, indicate higher 
cytotoxicity. In contrast, the surfactant 77KL with an inorganic lithium counterion was the 
most cytotoxic to 3T6 and NCTC 2544 cells (IC50 -values ranging from 103.67 to 146.23 
µg/ml), while it had only mild toxic effects on 3T3 and HaCaT cells, with IC50 -values 
ranging from 143.07 to 316.97 µg/ml. Moreover, 77KL was the least cytotoxic surfactant 
on the tumor cell lines, showing a cytotoxic effect (IC50) only at 468.53 and 350.07 µg/ml 
for MCF-7 cells, and 351.23 and 244.10 µg/ml for HeLa cells, by the NRU and MTT 
assays, respectively. On the basis of the mean cytotoxicity of the surfactants on each cell 
line, as established by the MTT and NRU assays, we ranked the compounds from the least 
to the most cytotoxic as follows: 77KK < 77KT < 77KL < 77KP < 77KS. 
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3.2. Comparative analyses between cell lines and cytotoxicity assays 
 The IC50 -values of the six cell lines obtained from the MTT and NRU assays were 
analyzed by one-way ANOVA followed by Tukey’s posthoc test to identify significant 
differences (Table 1). Of note the response of 3T3 cells to the five surfactants differed 
significantly from almost all the other cell lines, as determined by the MTT assay. The 
NRU assay showed that the sensitivity of 3T6 and NCTC 2544 cells to the surfactants did 
not differ significantly from each other, but showed significant differences from all the 
other cell lines, except in response to 77KS, as this surfactant produced fewer differences 
between the cell lines. 
Correlation analyses were performed to examine the relationship between the cell 
types. In general, poor correlations were obtained between the cell lines, even when the 
comparisons were performed only with the IC50 -values derived from the same 
cytotoxicity assay. Nevertheless, significant correlations were obtained for some 
combinations of cells and endpoints (Table 2).  
 Furthermore, correlation analyses between the MTT and NRU assays (IC50 -
values) for each surfactant in the six cell lines was performed by mean square root linear 
regression analysis. The relationship between the assays was expressed by their equations 
of linear regression and by Pearson’s correlation coeficient (r). Significant correlations 
were obtained for 77KK (p < 0.05), 77KL (p < 0.05) and 77KS (p < 0.05), and also when 
the responses for all five surfactants were correlated simultaneously (p < 0.01). These 
observations indicate that, despite the individual characteristics of each cell line and 
compound tested, in general relatively good agreement was obtained between the two 
cytotoxicity assays (Fig. 5). 
 
4. Discussion 
   
 In vitro cytotoxicity assays with established cell lines are useful tools for the 
general screening of chemicals in toxicological studies (Crespi, 1995). Surfactants are 
among the most versatile and widely used excipients in pharmaceutical products, and thus 
research on their toxic effects are required before they are considered for potential 
applications in topical drugs, cosmetic products (Martinez et al., 2006; Sanchez et al., 
2004, 2006a), and drug delivery systems (Nogueira et al., 2011; Wang et al., 2007). It has 
been reported that the type of (co) surfactant in topical pharmaceuticals and 
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nanoparticulate devices has great impact in their potential cytotoxic effects (Schöler et al., 
2001; Weyenberg et al., 2007). 
 Here we studied the sensitivity of several tumor and non-tumor cell lines to the 
toxic effects of five anionic lysine-based surfactants that differ in the nature of their 
counterions. For this purpose, we compared the performance of the MTT and NRU 
assays, two widely used and relatively simple in vitro bioassay methods that provide 
information on cell metabolic activity and membrane integrity (particularly in the 
lysosomal compartment), respectively. A comparative study based on a range of different 
cell lines and in vitro endpoints are highly suitable during toxicity screening of chemicals 
with potential interest in the pharmaceutical industry. The information derived from a 
more complete study can raise the knowledge concerning to the safety profile of bioactive 
compounds. Data on HaCaT, 3T6 and NCTC 2544 cell lines have been previously 
reported by our group (Sanchez et al., 2004, 2006a); however, in this work we used the 
raw data to recalculate the IC50 -values using a properly fitted regression model.  
 The cytotoxicity assays indicated significant differences between the cell lines 
(Table 1) in their sensitivity to the five compounds tested. Our observations are consistent 
with earlier studies that reported significant differences in the cytotoxic effects of 
chemicals depending on the cell type tested (Backorová et al., 2011; Burlando et al., 2008; 
Lestari et al., 2005; Schröterová et al., 2009; Tan et al., 2008; Wang et al., 2002). 
Although the effect of the surfactants was concentration-dependent, the cellular attributes 
of each particular tumor or non-tumor cell line also contributed to the overall outcome. 
The greater resistance of the tumor cell lines could be partly explained by the fact that 
healthy and cancer cells show differences in their structure and function, such as 
differences in metabolic activity and molecular composition (Frey et al., 2007). The 
particular characteristics of each cell type could lead to varied mechanisms of defense, 
and consequently distinct sensitivity to the toxic effect of a chemical compound. The 
overall variability in cell sensitivity was supported by the general poor or moderate 
correlation between cell lines (r < 0.85, correlation not significant). Nevertheless, some 
significant correlations were obtained. The two tumor cell lines (HeLa and MCF-7) 
presented a relatively good relationship with each other and also with the 3T3 non-tumor 
cell line. HeLa and MCF-7 cells have similar phenotypic characteristics (Leporatti et al., 
2009), which could explain their similar sensitivity to surfactants. In contrast, no 
significant correlations were found between the fibroblasts (3T3 and 3T6) or keratinocytes 
(HaCaT and NCTC 2544). The increased sensitivity of 3T6 and NCTC 2544 cells to the 
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surfactants may explain this lack of correlation. Hayat and Friedberg (1986) reported 
stronger cytotoxicity in transformed 3T6 cells compared to their untransformed 
counterparts 3T3 cells, which is consistent with our findings. The high resistence of 3T3 
cells could be partly explained by their sensitivity to growth contact inhibition in contrast 
to 3T6 cells (Todaro and Green, 1963). The contact inhibition property could favor a more 
differentiated phenotype for the 3T3 cells, in which the cytotoxic effect of the surfactant 
may be less potent. Moreover, cytotoxicity and phototoxicity studies have shown that 
HaCaT keratinocytes are more resistant than NCTC 2544 (Burlando et al., 2008; Leccia et 
al., 1998). The lower sensitivity of HaCaT cells could be attributed to their high degree of 
differentiation, which involves more developed keratinization, whereas NCTC 2544 cells 
are scarcely differentiated (Boukamp et al., 1988). Based on the variability of cell 
responses, we recommended a combination of cell lines of different origins for a reliable 
primary screening for the potential toxicity of chemical compounds with potential 
biomedical applications. Cell -culture systems with established banked cell lines are 
reproducible and high throughput approaches, and thus can provide a forecast of some 
adverse effects prior to human exposure. 
 Our results show that the MTT assay was more sensitive in detecting cell damage 
than NRU assay, regardless of the cell line or compound assessed. MTT assay revealed 
loss of viability at concentrations at which no significant cytotoxic effect was observed 
with the NRU assay. These results were not unexpected, since it has been previously 
reported that responses vary depending on the cytotoxicity assay used (Burlando et al., 
2008; Fotakis and Timbrell, 2006; Jondeau et al., 2006; Schröterová et al., 2009; 
Weyermann et al., 2005). Originally, it was assumed that the reduction of MTT occurred 
exclusively in the mitochondrial compartment; however, later studies showed that MTT is 
also reduced by oxido-reductase- type enzymes in microsomal and cytosolic fractions 
(Berridge et al., 2005; Liu et al., 1997). The NRU assay is based on the capacity of viable 
cells with intact plasma membranes to incorporate and bind the supravital NR dye in 
lysosomes. This process is dependent on the capacity of the cell to maintain pH gradients 
through the production of ATP (Repetto et al., 2008). The NRU endpoint is assumed to be 
universal among cell types, independently of their nature, while tetrazolium-based assays 
are more specific, as they measure the activity of intracellular enzymes whose expression, 
localization and activity depend on the cell type (Schröterová et al., 2009). Therefore, 
differences in cytotoxic responses could be related to specific toxicological mechanism of 
the surfactants tested as well as the characteristics of the cell lines. Moreover, the finding 
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that the NRU assay detected lower cytotoxicity than the MTT assay suggests that the 
mechanism of toxicity exerted by these surfactants involves an early effect on the 
metabolic activity of the cells, while plasma membrane and lysosomal compartments 
could be affected at a later stage. Although significant differences were found between the 
IC50 -values in some cell lines, significant correlations were obtained between the MTT 
and NRU assays for the surfactants 77KK, 77KL, 77KS, and also when all compounds 
were correlated simultaneously. This generally good relationship between the two 
endpoints even when individual differences were observed within experimental data is in 
agreement with previous studies (Borenfreund et al., 1988). On the basis of our results, we 
recommend that the inter-correlation data from these two assays be carefully analyzed 
before considering similar tools for the overall evaluation of cytotoxicity. The 
combination of several endpoints might be recommendable in order to distinguish 
between the effects on specific organelles or general cytotoxicity. 
 It is worth mentioning that compounds containing counterions differ in their 
capacity to interact with biological membranes, and the type of counterion is one of the 
factors that determine the efficiency of this interaction (Kleszczynska et al, 1998; 
Nogueira et al., 2011). Therefore, given that the class of lysine-based surfactants studied 
here had the same chemical structure, differing only in the type of counterion, the 
characteristics of the counterion may be crucial to the cytotoxic effect. Surfactants bound 
to heavy counterions, lysine (77KK) and tris (77KT), showed low toxicity. On the basis of 
this observation, we suggest that there is a relationship between the size of the counterion 
and the cytotoxic properties of these compounds: the heavier the counterion they are 
bound to, the lower the cytotoxicity they induce. This finding could be explained by the 
influence of the volume of surfactant polar head on cell membrane penetration. The larger 
the volume and radius of the polar head, the lower the penetration, which would explain 
why high concentrations of these surfactants were required to membrane penetration 
(Maugras et al., 2001; Sarapuk et al., 1997; Selve et al., 1991). In contrast, surfactant 
77KL was the least cytotoxic to tumor cells, indicating a specific interaction of the 
inorganic lithium counterion with these cells. Moreover, surfactant 77KS was one of the 
most cytotoxic compounds regardless of the assay or cell line used. This observation 
suggests non-specific toxicity of the inorganic sodium counterion in the assays and cell 
lines assessed.  
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5. Conclusions 
 
Our results show significant differences in the cytotoxicity of the surfactants. 
These differences are attributed to differences in the sensitivity of model cell lines to these 
compounds and the characteristics of the two assays used. The two tumor cells and 3T3 
fibroblasts were more resistant to the surfactants, while 3T6 and NCTC 2544 cells were 
the most sensitive. The MTT assay was more sensitive in detecting cell damage, 
regardless of the cell line or compound tested. We conclude that the type of counterion in 
these compounds determines the degree of surfactant interaction with the cell: in general 
the compounds with organic counterions are the least cytotoxic. The outcome of this study 
enhances knowledge about the potential toxic effects of novel biocompatible lysine-based 
surfactants prior to preformulation trials of pharmaceutical devices. Altogether, our 
findings highlight the relevance of an appropriate choice and combination of endpoints 
and cell -culture systems in toxicity studies, which may raise the information output 
related to all major toxic effects of bioactive compounds. A complete and detailed 
toxicological evaluation in vitro may increase the reliability of results, and also prevent 
overestimation or underestimation of cytotoxicity. Furthermore, this comparative study, 
performed with six different cell types and two endpoints, may also serve as a basis for 
further toxicological screenings of different chemical compounds. 
 
 
Conflict of interest statement 
 
The authors have declared no conflict of interest. 
 
 
Acknowledgements 
 
This research was supported by Project CTQ2009-14151-C02-02 from Ministerio de 
Ciencia e Innovación (Spain). Daniele Rubert Nogueira holds doctoral grant from MAEC-
AECID (Spain). 
  
 14 
References 
 
Backorová, M., Backor, M., Mikes, J., Jendzelovsky, R., Fedorocko, P., 2011. Variable 
responses of different human cancer cells to the lichen compounds parietin, atranorin, 
usnic acid and gyrophoric acid. Toxicol. in Vitro 25, 37-44. 
Benassi, L., Bertazzoni, G., Magnoni, C., Rinaldi, M., Fontanesi, C., Seidenari, S., 2003. 
Decrease in toxic potential of mixed tensides maintained bellow the critical micelle 
concentration: an in vitro study. Skin Pharmacol. Appl. Skin Physiol. 16, 156-164. 
Benavides, T., Martinez, V., Mitjans, M., Infante, M.R., Moran, C., Clapés, P., Clothier, 
R., Vinardell, M.P., 2004a. Assessment of the potential irritation and photoirritation of 
novel amino acid-based surfactants by in vitro methods as alternatives to the animal 
tests. Toxicology 201, 87-93. 
Benavides, T., Mitjans, M., Martinez, V., Clapés, P., Infante, M.R., Clothier, R.H., 
Vinardell, M.P., 2004b. Assessment of primary eye and skin irritants by in vitro 
cytotoxicity and phototoxicity models: an in vitro approach of new arginine-based 
surfactant –induced irritation. Toxicology 197, 229-237. 
Berridge, M.V., Herst, P.M., Tan, A.S., 2005. Tetrazolium dyes as tools in cell biology: 
New insights into their cellular reduction. Biotechnol. Annu. Rev. 11, 127-152. 
Borenfreund, E., Puerner, J.A., 1985. Toxicity determined in vitro by morphological 
alterations and neutral red absorption. Toxicol. Lett. 24, 119-124. 
Borenfreund, E., Babich, H., Martin-Alguacil, N., 1988. Comparisons of two in vitro 
cytotoxicity assays. The neutral red (NR) and tetrazolium MTT test. Toxicol. in Vitro 
2, 1-6. 
Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A., Fusenig, 
N.E., 1988. Normal keratinization in a spontaneously immortalized aneuploid human 
keratinocyte cell line. J. Cell Biol. 106, 761-771. 
Burlando, B., Parodi, A., Volante, A., Bassi, A.M., 2008. Comparison of the irritation 
potentials of Boswellia serrata gum resin and of acetyl-11-keto-β-boswellic acid by in 
vitro cytotoxicity tests on human skin-derived cell lines. Toxicol. Lett. 177, 144-149. 
Crespi, C.L., 1995. Xenobiotic-metabolizing human cells as tools for pharmacological and 
toxicological research. Adv. Drug Res. 26, 179-235. 
Fisher, D., Youxin, L., Ahlemeyer, B., Krieglstein, J., Kissel, T., 2003. In vitro 
cytotoxicity testing of polications: influence of polymer structure on cell viability and 
hemolysis. Biomaterials 24, 1121-1131. 
Fotakis, G., Timbrell, J.A., 2006. In vitro cytotoxicity assays: Comparison of LDH, 
neutral red, MTT and protein assay in hepatoma cell lines following exposure to 
cadmium chloride. Toxicol. Lett. 160, 171-177. 
Frey, C., Pavani, M., Cordano, G., Muñoz, S., Rivera, E., Medina, J., Morillo, A., Maya, 
J.D., Ferreira, J., 2007. Comparative cytotoxicity of alkyl gallotes on mouse tumor cell 
lines and isolated rat hepatocytes. Comp. Biochem. Physiol., Part A Mol. Integr. 
Physiol. 146, 520-527. 
 15 
Hayat, H., Friedberg, I., 1986. Heat-induced alterations in cell membrane permeability 
and cell inactivation of transformed mouse fibroblasts. Int. J. Hyperthermia 2, 369-
378. 
Jondeau, A., Dahbi, L., Bani-Estivals, M.-H., Chagnon, M.-C., 2006. Evaluation of the 
sensitivity of three sublethal cytotoxicity assays in human HepG2 cell line using water 
contaminants. Toxicology 226, 218-228. 
Kim, H., Yoon, S.C., Lee, T.Y., Jeong, D., 2009. Discriminative cytotoxicity assessment 
based on various cellular damages. Toxicol. Lett. 184, 13-17. 
Kleszczynska, H., Sarapuk, J., 1998. The role of counterions in the protective action of 
some antioxidants an the process of red cell oxidation. Biochem. Mol. Biol. Int. 46, 
385-390. 
Leccia, M.-T., Richard, M.-J., Joanny-Crisci, F., Beani, J.-C., 1998. UV-A1 cytotoxicity 
and antioxidant defence in keratinocytes and fibroblasts. Eur. J. Dermatol. 8, 478-482. 
Leporatti, S., Vergara, D., Zacheo, A., Vergaro, V., Maruccio, G., Cingolani, R., Rinaldi, 
R., 2009. Cytomechanical and topological investigation of MCF-7 cells by scanning 
force microscope. Nanotechnology 20, 1-6. 
Lestari, F., Hayes, A.J., Green, A.R., Markovic, B., 2005. In vitro cytotoxicity of selected 
chemicals commonly produced during fire combustion using human cell lines. 
Toxicol. in Vitro 19, 653-663. 
Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., 1997. Mechanism of cellular 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. 
Neurochem. 69, 581-593. 
Martinez, V., Corsini, E., Mitjans, M., Pinazo, A., Vinardell, M.P., 2006. Evaluation of 
eye and skin irritation of arginine-derivative surfactants using different in vitro 
endpoints as alternatives to the in vivo assays. Toxicol. Lett. 164, 259-267. 
Maugras, M., Infante, M.R., Gerardin, Ch., Selve, C., Vinardell, M.P., 2001. Possible 
effects of counterions on biological activities of anionic surfactants. Comp. Biochem. 
Physiol. C 128, 541-545. 
Mitjans, M., Martinez, M., Clapés, P., Pérez, L., Infante, M.R., Vinardell, M.P., 2003. 
Low potential ocular irritation of arginine-based gemini surfactants and their mixtures 
with nonionic and zwitterionic surfactants. Pharm. Res. 20, 1697-1701. 
Morán, M.C., Infante, M.R., Miguel, M.G., Lindman, B., Pons, R., 2010. Novel 
Biocompatible DNA Gel Particles. Langmuir 26,10606-10613. 
Mosmann, T., 1983. Rapid colorimetric assay to cellular growth and survival: application 
to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63. 
Nogueira, D.R., Mitjans, M., Infante, M.R., Vinardell, M.P., 2011. The role of 
counterions in the membrane-disruptive properties of pH-sensitive lysine-based 
surfactants. Acta Biomater., doi: 10.1016/j.actbio.2011.03.017. 
Paulsson, M., Edsman, K., 2001. Controlled drug release from gels using surfactants 
aggregates. Part II: vesicles formed from mixtures of amphiphilic drugs and 
oppositely charged surfactants. Pharm. Res. 18, 1586-1592. 
Repetto, G., Peso, A., Zurita, J.L., 2008. Neutral red uptake assay for the estimation of 
cell viability/cytotoxicity. Nat. Protoc. 3, 1125-1131. 
 16 
Sanchez, L., Mitjans, M., Infante, M.R., Vinardell, M.P., 2004. Assessment of the 
potencial skin irritation of lysine-derivative anionic surfactants using mouse 
fibroblasts and human keratinocytes as an alternative to animal testing. Pharm. Res. 
26, 1637-1641. 
Sanchez, L., Mitjans, M., Infante, M.R., Vinardell, M.P., 2006a. Potential irritation of 
lysine derivative surfactants by hemolysis and HaCaT cell viability. Toxicol. Lett. 
161, 53-60. 
Sanchez, L., Mitjans, M., Infante, M.R., Vinardell, M.P., 2006b. Determination of 
interleukin-1α in human NCTC 2544 keratinocyte cells as a predictor of skin irritation 
from lysine-based surfactants. Toxicol. Lett. 167, 40-46. 
Sarapuk, J., Babrielska, J., Przestalski, S., 1997. Modification of model membrane by new 
bifunctional surfactants. Curr. Topics. Biophys. 21, 54-57. 
Schöler, N., Olbrich, C., Tabatt, K., Müller, R.H., Hahn, H., Liesenfeld, O., 2001. 
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and 
cytokine production of macrophages. Int. J. Pharm. 221, 57-67. 
Schröterová, L., Králová, V., Vorácová, A., Hasková, P., Rudolf, E., 2009. 
Antiproliferative effects of selenium compounds in colon cancer cells: Comparison of 
different cytotoxicity assays. Toxicol. in Vitro 23, 1406-1411. 
Selve, C., Delestre, C., Achilefu, S., Maugras, M., Attioui, F.J., 1991. Synthesis and 
evaluation of the properties of fluorinated amphiphilic amides of 2,2-
bis(hydroxymethyl) propionic acid. Chem. Soc. Chem. Com. 13, 837-904. 
Tan, F., Wang, M., Wang, W., Lu., Y., 2008. Comparative evaluation of the cytotoxicity 
sensitivity of six fish cell lines to four heavy metals in vitro. Toxicol. in Vitro 22, 164-
170. 
Todaro, G.J., Green, H., 1963. Quantitative studies of the growth of mouse embryo cells 
in cultura and their development into established lines. J. Cell Biol. 17, 299-313. 
Vives, M.A., Infante, M.R., Garcia, E., Selve, C., Maugras, M., Vinardell, M.P., 1999. 
Erythrocyte hemolysis and shape changes induced by new lysine-derivative 
surfactants. Chem. Biol. Interact. 118, 1-18. 
Wang, K., Shindoh, H., Inoue, T., Horii, I., 2002. Advantages of in vitro cytotoxicity 
testing by using primary rat hepatocytes in comparison with established cell lines. J. 
Toxicol. Sci. 27, 229-237. 
Wang, X.-L., Ramusovic, S., Nguyen, T., Lu, Z.-R., 2007. Novel polymerizable 
surfactants with pH-sensitive amphiphilicity and cell membrane disruption for 
efficient siRNA delivery. Bioconjug. Chem. 18, 2169-2177. 
Weyenberg, W., Filev, P., Van den Plas, D., Vandervoort, J., De Smet, K., Sollie, P., 
Ludwig, A., 2007. Cytotoxicity of submicron emulsions and solid lipid nanoparticles 
for termal application. Int. J. Pharm. 337, 291-298. 
Weyermann, J., Lochmann, D., Zimmer, A., 2005. A pratical note on the use of 
cytotoxicity assays. Int. J. Pharm. 288, 369-376. 
 17 
Figure captions: 
 
Fig. 1. Molecular structure of anionic lysine-based surfactants with distinct counterions. 
The codes P, L, S, K and T represent potassium, lithium, sodium, lysine and Tris, 
respectively. 
 
Fig. 2. Representative concentration-response curves from 24-h exposure of the two 
tumor and four non-tumor cell lines to surfactants with organic counterions: 77KK (panels 
a and b) and 77KT (panels c and d). Values were obtained from NRU (panels a and c) and 
MTT (panels b and d) assays. Data are expressed as mean ± S.E.M. of three independent 
experiments, performed in triplicate.  
 
Fig. 3. Representative concentration-response curves from 24-h exposure of the two 
tumor and four non-tumor cell lines to surfactants with inorganic counterions: 77KL 
(panels a and b), 77KP (panels c and d) and 77KS (panels e and f). Values were obtained 
from NRU (panels a, c and e) and MTT (panels b, d and f) assays. Data are expressed as 
mean ± S.E.M. of three independent experiments, performed in triplicate.  
 
Fig. 4. Cytotoxicity of the lysine-based surfactants expressed as IC50 -values (μg/ml) on 
(a) 3T3, (b) 3T6, (c) HaCaT, (d) NCTC 2544, (e) HeLa and (f) MCF-7 cell lines, and 
measured by NRU (dark bars) and MTT (white bars) assays. Data are expressed as mean 
± S.E.M. of three independent experiments, performed in triplicate. NRU and MTT assays 
were compared by the Student’s t-test. * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001 
denote significant differences. 
 
Fig. 5. Correlation of IC50-values (μg/ml) between the NRU and MTT assays. (a) 77KK, 
(b) 77KT, (c) 77KL, (d) 77KP, (e) 77KS and (f) all surfactants. (1) 3T3, (2) 3T6, (3) 
HaCaT, (4) NCTC 2544, (5) HeLa and (6) MCF-7. r = Pearson’s correlation coefficient. * 
p < 0.05, 
** 
p < 0.01 denote significant correlation. 
 
Table 1. One-way ANOVA results and multiple comparison of cell types 
a
 
 
 NRU MTT 
 77KK 77KT 77KL 77KP 77KS 77KK 77KT 77KL 77KP 77KS 
One-way ANOVA p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
3T3 vs 3T6 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
3T3 vs NCTC p<0.001 p<0.001 p<0.001 p<0.001 p<0.005 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 
3T3 vs HaCaT NS NS NS NS p<0.005 p<0.005 p<0.001 p<0.001 p<0.001 p<0.001 
3T3 vs HeLa NS NS NS NS p<0.05 p<0.001 p<0.001 NS NS p<0.001 
3T3 vs MCF-7 NS NS p<0.001 NS NS NS NS NS p<0.001 p<0.001 
3T6 vs NCTC NS NS NS NS NS NS NS NS NS NS 
3T6 vs HaCaT p<0.001 p<0.001 p<0.001 p<0.05 NS p<0.001 NS NS NS NS 
3T6 vs HeLa p<0.001 p<0.001 p<0.001 p<0.05 NS p<0.005 p<0.05 p<0.001 p<0.005 NS 
3T6 vs MCF-7 p<0.001 p<0.001 p<0.001 p<0.005 p<0.005 p<0.001 p<0.001 p<0.001 NS NS 
NCTC vs HaCaT p<0.001 p<0.001 p<0.001 p<0.05 NS p<0.05 NS NS NS NS 
NCTC vs HeLa p<0.001 p<0.001 p<0.001 p<0.05 NS NS NS p<0.001 p<0.005 NS 
NCTC vs MCF-7 p<0.001 p<0.001 p<0.001 p<0.005 NS p<0.001 p<0.001 p<0.001 NS NS 
HaCaT vs HeLa NS NS NS NS NS NS NS p<0.005 p<0.005 NS 
HaCaT vs MCF-7 NS NS p<0.001 NS NS p<0.005 p<0.001 p<0.001 NS NS 
HeLa vs MCF-7 NS NS p<0.001 NS NS p<0.001 p<0.001 p<0.005 p<0.005 NS 
NS = not statistically significant 
a 
One-way analysis of variance; posthoc multiple comparison by the Tukey test. 
 
Table(s)
Table 2. Significant correlations of IC50 -values between the cell types studied by using NRU and 
MTT cytotoxicity assays 
 
Cell line – Cytotoxicity assay Pearson’s correlation coeficient p value 
3T3 NRU vs HaCaT NRU 0.930 p < 0.05 
3T3 MTT vs HaCaT NRU 0.899 p < 0.05 
3T3 MTT vs MCF-7 NRU 0.983 p < 0.01 
3T3 MTT vs MCF-7 MTT 0.994 p < 0.01 
HeLa NRU vs HaCaT NRU 0.959 p < 0.05 
HeLa NRU vs MCF-7 NRU 0.961 p < 0.01 
HeLa NRU vs MCF-7 MTT 0.986 p < 0.01 
HeLa NRU vs 3T3 MTT 0.982 p < 0.01 
HeLa MTT vs NCTC 2544 NRU 0.953 p < 0.05 
HaCaT MTT vs 3T6 NRU 0.918 p < 0.05 
MCF-7 MTT vs HaCaT NRU 0.910 p < 0.05 
MCF-7 MTT vs MCF-7 NRU 0.989 p < 0.01 
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